Background--Neuroinflammation plays a key role in intracerebral hemorrhage (ICH)-induced secondary brain injury, but the specific roles of peripheral inflammatory cells such as macrophages and lymphocytes remain unknown. The purpose of this study was to explore the roles of macrophages, T lymphocytes, and the cytokines they secrete as potential targets for treating secondary brain injury after ICH.
I
ntracerebral hemorrhage (ICH) accounts for 20% to 30% of all cases of cerebrovascular disease in China and remains the leading cause of mortality, largely because there currently is no specific treatment. [1] [2] [3] ICH is associated with both primary and secondary injury. The physical effects of the hematoma (mass effect) and disturbance of the adjacent tissue that occur within hours of the onset of bleeding represent the primary insult. 4 The potential benefit of clot removal has been investigated in multiple clinical trials but not confirmed. [4] [5] [6] Instead, most recent attempts to identify novel therapeutic targets have focused on the mechanisms responsible for ICHinduced secondary injury, which is caused by the development of edema, free radicals, inflammation, and direct cellular toxicity of the degradation by products of the hematoma. 4 Increasing evidence indicates that inflammation plays a critical role in ICH-induced secondary injury. [7] [8] [9] Within minutes after ICH, microglia are activated and begin to release large amounts of cytokines and chemokines to destroy the blood-brain barrier (BBB). 8, 10 In the later phase, peripheral inflammatory cells such as macrophages and lymphocytes are mobilized to the perihematoma brain tissue through the damaged BBB.
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The infiltrating macrophages and T lymphocytes further produce proinflammatory factors to exacerbate brain edema and neurologic deficits after ICH. 12, 14 However, little is known about the mechanisms by which macrophages and lymphocytes are activated after ICH as well as the proinflammatory factors they release to induce the later brain injury. Among the proinflammatory factors released within the injured brain, interleukin (IL)-17 generated by IL-17-expressing helper T (Th17) cells has been shown to induce inflammation in experimental autoimmune encephalomyelitis (EAE), which is a mouse model of multiple sclerosis. 15, 16 Research has also
shown that IL-23, a heterodimer of the IL-23p19 and Il-12p40 subunits, released by activated macrophages and dendritic cells (DCs) can induce differentiation of CD4 + T cells into Th17 cells to generate a major inflammatory reaction. 17, 18 This IL-23/IL-17 inflammatory axis has been shown to be essential for the onset and progression of autoimmune inflammatory diseases in multiple mouse models, including EAE 18 and collagen-induced arthritis. 19 Moreover, the T-lymphocyte production of IL-17 in response to macrophage-derived IL-23 was found to play a critical role in the later stage of brain infarction. 20, 21 These data highlight an important role of the IL-23/IL-17 inflammatory axis in the acute neuroinflammatory response. However, the roles of macrophages and T lymphocytes as well as the IL-23/IL-17 inflammatory axis within the neuroinflammation that occurs after ICH remain to be determined. The purpose of this study was to explore the roles of macrophages, T lymphocytes, and the cytokines they secrete in the secondary brain injury caused by ICH. ICH was induced using an established model in various lines of knockout mice, and the molecular events underlying the resulting neuroinflammatory responses were studied. The results of these experiments provide insight into the mechanisms of the neuroinflammation responsible for secondary brain injury after ICH and provide new targets for the development of therapies for ICH patients. 
Materials and Methods

Animals
/TLR4
À/À mice, as previously reported. 22 All animal experiments were performed in compliance with the Guide for the Care and Use of Laboratory Animals, 8th edition (2011) and ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines.
ICH Model
A previously reported model of ICH employing autologous blood was used in this study. 23, 24 After mice were anesthetized by intraperitoneal (i.p.) injection of 80 mg/kg phenobarbital, they were fixed on a mouse stereotaxic frame (Stoelting, Wood Dale, IL). Then 20 lL of autologous blood collected from the tail vein and not treated with an anticoagulant was injected into the caudate nucleus using a syringe pump (KD Scientific, Holliston, MA) at 0.8 mm anterior, 2 mm right lateral, and 3.5 mm deep from the bregma. During the procedure, body temperature was kept at 37°C, and the mice had free access to food and water once awake. Mice that died were excluded from the study.
Cell Isolation and Adoptive Transfer in Mice
Based on previously reported methods, 25 CD3 + T lymphocytes (with a purity >90%) were isolated from the spleen of wild-type (WT) mice by following the manufacturer's instructions for the mouse CD3e microbead kit (Miltenyi Biotec, Cologne, Germany). The isolated CD3 + T lymphocytes ( 1910 7 ) were transfused back into the Rag1 À/À mice intravenously 5 days before ICH.
BM-Chimeric Mice
According to previously reported methods, 20 
SsnB Administration
Our previous research revealed that sparstolonin B (SsnB) reduces lipopolysaccharide-induced Nuclear factor kappa B (NF-jB) activity in a dose-dependent manner, and the halfmaximal inhibitory concentration of SsnB is %10 lmol/L.
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For in vitro experiments, SsnB (1, 10, or 50 lmol/L) was dissolved in polyethylene glycol 400 and added to the cell culture medium for 3 hours. For in vivo experiments, SsnB was injected intravenously into mice at a dose of 1, 5, or 10 mg/kg at 2 hours after induction of ICH with different administration protocols (twice a day, once daily, or once every 2 days for 3 successive days). Because a dose of 5 mg/kg once daily achieved the maximum inhibitory effect on neurologic deficit score (NDS) after ICH (data not shown), the protocol (5 mg/kg SsnB injected 2 hours after ICH and once daily for the next 3 consecutive days) was used to test the therapeutic effects of SsnB on ICH mice. Mice in the control group received the same volume of vehicle.
Cell Culture
Bone marrow DCs
As previously described, 27 BM was collected from the tibias and femurs of C57BL/6, TLR2
, and TRIF À/À mice. BM cells were passed through a nylon mesh and then cultured for 8 days in RPMI-1640 medium with 10% fetal calf serum and 1 lg/mL mouse granulocyte-macrophage colony-stimulating factor Recombinant Protein (eBioscience, San Diego, CA). 
HEK-293 cells
Real-Time PCR Analysis
Real-time polymerase chain reaction (PCR) analysis was performed with the primers listed in 
Western Blot Analysis
According to previously reported methods, 22 proteins from perihematoma tissues were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene fluoride membranes via electroblotting. Membranes were incubated with IL-23p19 antibody (rabbit polyclonal antibody to IL-23p19, 1:200, Abcam, Cambridge, UK) or IL-17 antibody (rabbit polyclonal antibody to IL-17, 1:400; Abcam) at 4°C overnight, and the next day membranes were incubated with horseradish peroxidaseconjugated goat antimouse secondary antibody (1:300; Santa Cruz Biotechnology, Santa Cruz, CA) at 25°C for 1.5 hour. A chemiluminescence detection system was used to observe the resulting protein bands.
Immunoprecipitation
Cultured cells or infiltrating inflammatory cells sorted by fluorescence-activated cell sorting (FACS) were lysed in radio immunoprecipitation assay (RIPA) lysis buffer as previously described. 22 The extracted protein was then incubated with antibody to mouse TLR2 (1:100, Abcam), TLR4 (1:100, Abcam), or IgG as a control (1:100, Abcam) at 4°C overnight, followed by addition of unblocked protein A beads (1:400, Abcam) for 2 hours. After centrifugation, the immunoprecipitates were resuspended in SDS-PAGE buffer and subjected to Western blot analysis to quantify protein expression.
Immunofluorescence and TUNEL Staining
Immunofluorescence staining was performed on brain tissue sections (thickness of 25 lm) and cultured BM-derived DCs (BMDCs) using the primary and secondary antibodies listed in Table S2 as well as 4 0 -6-diamidino-2-phenylindole (DAPI; 0.5 lg/mL; Roche, Indianapolis, IN). For staining, samples were blocked with goat serum, incubated with the primary antibodies at 4°C overnight, washed, and then exposed to secondary antibodies at 25°C for 1 hour.
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining was performed using the In Situ Cell Death Detection Kit of Roche Molecular Biochemicals (Mannheim, Germany), according to the manufacturer's instructions.
All stained sections were examined using a confocal laser microscope (Leica, Hamburg, Germany). Positively stained cells were counted on the cortex around the hematoma. The number of positive cells within 3 regions of interest, each 0.1 mm 2 was expressed as an averaged value. Photomicrograph overlay and mild adjustment of contrast and brightness were achieved using Adobe Photoshop CS3 (Adobe Systems, San Jose, CA). Three trained researchers who were blinded to the grouping information performed the counting.
Flow Cytometry
Preparation of inflammatory cells in perihematomal tissues
Single-cell suspensions of brain cells were prepared as previously described. 28, 29 Briefly, at the designated time points, mice (n=5-8) were perfused transcardially using icecold PBS to clear blood cells before dissection of the forebrain from the cerebellum. The harvested brain tissue was suspended in RPMI-1640 medium and then digested in a 37°C shaker rotating at 180 rpm for 45 minutes upon addition of type IV collagenase (1 mg/mL; Sigma-Aldrich, St. Louis, MO) and DNase I (50 mg/mL, Roche). From the brain tissue, inflammatory cells were isolated by 37% to 70% Percoll (GE Healthcare) density gradient centrifugation as previously described 30 and then washed with RPMI-1640 prior to flow cytometric analysis.
Surface marker and intracellular cytokine staining
For surface and intracellular cytokine staining, infiltrating inflammatory cells isolated by Percoll density gradient centrifugation as described above were stimulated for 5 hours with 50 nmol/L phorbol 12-myristate 13-acetate (SigmaAldrich), 1 lg/mL ionomycin (Sigma-Aldrich), and 1 lmol/L 
FACS analysis
FACS analysis was performed using a FACSVerse analyzer (BD Biosciences, San Jose, CA), and the data were analyzed using FlowJo software 7.6.1 (FlowJo, LLC, Ashland, OR).
NF-jB Activity
According to a previously reported method, 22 HEK-293 cells (ATCC, 1910 7 ) were transfected with both NF-jB-luciferase reporter gene (Addgen.org, plasmids 13642) and pcDNA3.1 vectors containing TLR2-YFP, TLR4-YFP, or MyD88 (Addgen.org, plasmids 13016, 13018, and 13026, respectively) and fused to yellow fluorescent protein (YFP). Mutation of the Arg196 of MyD88 was conducted as previously reported.
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Forty-eight hours after cotransfection, cells were stimulated under the specified conditions for 12 hours. Cells were subsequently lysed, and reporter gene activity was measured using a Dual Luciferase Assay Reporter System (E1910, Promega, Madison, WI).
Liquid Chromatography-Mass Spectrometry
Four days after ICH, WT mice were intravenously injected with SsnB at a dose of 5 mg/kg in polyethylene glycol 400, and mice in the control group received the same volume of vehicle intravenously. Cerebral tissues were sampled at 10, 20, and 30 minutes after injection. SsnB levels in the harvested samples were measured using liquid chromatography-mass spectrometry (LC-MS) (6410B Triple Quad LC/MS, Agilent Technologies, Palo Alto, CA).
Brain Water Content
Brain water content (BWC) was measured in mouse cerebral tissues after ICH as previously described. 22 Briefly, the surface water on harvested cerebral tissue samples was blotted with filter paper, and the cerebellum and contralateral cerebral hemisphere were removed. Brain samples were immediately weighed on an electric analytic balance to obtain the wet weight and then dried at 100°C for 24 hours before measurement of the dry weight. BWC was calculated using the following formula: BWC (%)=(wet weight-dry weight)/wet weight9100%.
Neurologic Deficit Score
Multiple behavioral tests were applied to characterize neurological deficits as previously reported. 22, 31 Two trained investigators who were blinded to animal grouping performed the scoring, and the final score for each mouse was obtained by calculating the mean scores for the subscales.
Statistical Analysis
All statistical tests were performed using SPSS 18.0 software (IBM, Armonk, NY), and all data are presented as the meanAEstandard error. The significance of differences between 2 and ≥3 groups was determined using nonparametric tests, Student t test, and 1-way ANOVA followed by Scheffe post hoc test, respectively. The effects of multiple factors were studied via 2-way ANOVA with repeated measures. For all tests, P<0.05 was considered statistically significant.
Results
Infiltration of Peripheral Inflammatory Cells and Their Involvement in Secondary Injury After ICH
After induction of ICH in WT C57BL/6 mice, the temporal changes in the numbers of different types of inflammatory cells in the hemorrhagic hemisphere were analyzed by FACS. Microglia and macrophages were gated according to the fluorescence intensity of CD45 and CD11b staining. The CD45 high group was gated and further analyzed for the expression of CD3 and CD4. The CD45 high CD3 + cells were gated and further analyzed for the expression of cdT ( Figure S1 ). We observed the highest absolute numbers of CD45 + cells ( Figure 1A ), including T lymphocytes (CD3 + cells; Figure 1B ), CD4 + T lymphocytes ( Figure 1C ), and cdT lymphocytes ( Figure 1D ), on day 4 after ICH, while the number of macrophages peaked at day 1 ( Figure 1E ). In contrast, no changes in the numbers of microglia were observed after ICH ( Figure 1F ). In confirmation of these FACS results, immunofluorescence staining showed that F4/80 + (macrophages/ microglia; Figure 1G ) and CD3 + cells (T lymphocyte; Figure 1H) were located along the perihematoma area after ICH.
Because the absolute numbers of macrophages peaked on day 1 after ICH, we first explored whether macrophage infiltration of the brain is required for ICH-induced injury by depleting peripheral macrophages using CLPs. In these liposomes, clodronate is encapsulated at a concentration of 7 mg/mL, and systemic administration with a dose of 0.2 mL/20 to 25 g has been demonstrated to achieve efficient depletion of macrophages within 24 to 36 hours. 32, 33 We confirmed depletion of 76.2% of F4/80 + macrophages in the spleen of ICH mice at 4 days after the first CLP injection ( Figure S2 ). Intraperitoneal injection of CLPs also significantly reduced the number of infiltrating macrophages in the brain at 1 day and 4 days after ICH (Figure 2A) , without influencing the infiltration of T lymphocytes ( Figure 2B ). Moreover, we found that CLP injection significantly reduced the NDS ( Figure 2C ) and BWC ( Figure 2D ) of WT mice with ICH. These findings that macrophage depletion alleviated ICH-induced brain damage in mice suggest that macrophage infiltration plays a key role in ICH-induced brain injury.
We next investigated the role of T lymphocytes in ICHinduced secondary brain injury by using fingolimod to inhibit T-lymphocyte migration. At day 4 after the ICH in mice treated with fingolimod, no change was observed in macrophage infiltration ( Figure 2E ), but T-lymphocyte infiltration was significantly reduced ( Figure 2F ). In addition, we also found that fingolimod treatment ameliorated the neurologic deficit ( Figure 2G ) and BWC ( Figure 2H ) changes induced by ICH in WT mice over 7 days. To confirm that these protective effects of fingolimod were related to reduced infiltration of peripheral T cells, we performed adoptive transfer of T lymphocytes into mice deficient in recombination activating gene-1 (Rag1 À/À mice). First, we found that Rag1 À/À mice exhibited a lower NDS ( Figure 2I ) and BWC ( Figure 2J ) than WT mice after ICH, which was consistent with previous results for experimentally induced ischemic stroke. 34 Moreover, the NDS ( Figure 2I ) and BWC ( Figure 2J ) were increased when WT T lymphocytes were transferred into Rag1 À/À mice. These results suggest that infiltrating peripheral T lymphocytes can aggravate secondary brain injury in mice after ICH.
Hb-Induced TLR2/TLR4 Heterodimer Formation on Infiltrating Macrophages Aggravated Secondary Brain Injury After ICH
Our previous research showed that hemoglobin (Hb) promotes microglial activation by inducing the formation of TLR2/TLR4 heterodimers and then exacerbates brain injury following ICH by amplifying the production of inflammatory cytokines. 22 To determine whether Hb has a similar effect on infiltrating macrophages, we observed the colocalization of TLR2 and TLR4 on F4/80 + cells perihematomal in ICH mouse brain tissue by immunohistochemical staining ( Figure 3A ). + cell infiltration into the perihematoma area at 4 days after ICH (blue=DAPI, green=CD3, scale bars=100 lm).
However, F4/80 + cells included not only macrophages but also microglia. To clarify whether TLR2 and TLR4 colocalized on macrophages, we stimulated BMDCs with Hb (5 lmol/L, 3 hours) and observed colocalization of TLR2 and TLR4 on these cells ( Figure 3B ). Furthermore, to investigate the link between TLR2 and TLR4 on macrophages, we cultured BMDCs from WT mice and separated macrophages from the brain or spleen of WT mice at day 1 after ICH. Then immunoprecipitation assays were performed to detect the coprecipitation of TLR2 and TLR4 in those cells. Among the red blood cell found to induce coprecipitation of TLR2 and TLR4 ( Figure 3C ). Immunoprecipitation assays also revealed that Hb induced coprecipitation of TLR2 and TLR4 on brain-derived macrophages of ICH mice, but not on spleen-derived macrophages ( Figure 3D ). These findings suggest that Hb induces TLR2/ TLR4 heterodimer formation on macrophages located specifically in the brain but not in the peripheral region.
To test whether TLR2/TLR4 heterodimer on hematopoietic cells rather than resident brain cells plays a key role in ICHinduced secondary injury, we used BM-chimeric mice. The NDS ( Figure 3E 
IL-23p19 Produced by Infiltrating Macrophages Exacerbated Secondary Brain Injury Following ICH
IL-23p19 is known to play key roles in the establishment and maintenance of organ-specific inflammatory autoimmune diseases. 18, 19, 35, 36 To study IL-23p19 involvement in ICH-induced brain injury, Western blot and real-time PCR analyses were performed to detect IL-23p19 expression at days 1, 4, and 7 after ICH. Compared with those in sham controls, IL-23p19 protein ( Figure 4A ) and mRNA ( Figure 4B ) levels were significantly higher in the perihematoma tissues of ICH mice, peaking on day 1 after ICH ( Figure 4A and 4B). To further elucidate the role of IL-23p19, we compared ICH injury levels between IL23p19 À/À mice and WT mice. IL-23p19 À/À mice showed a lower NDS ( Figure 4C ) and BWC ( Figure 4D ) and fewer apoptotic neurons after ICH ( Figure 4E and 4F) than WT mice. In addition, IL-1b and tumor necrosis factor-a (TNF-a) gene expression in infiltrating CD45 + cells was significantly lower in IL-23p19 À/À mice than in WT mice at day 4 after ICH ( Figure 4G ). These results suggest that IL-23p19 contributed to brain injury after ICH, which prompted us to next investigate the source of IL-23p19 in the injured brain. IL-23p19 mRNA expression on infiltrating inflammatory (CD45 + ) cells was highest at day 1 after ICH ( Figure 4H ), corresponding to the peak in macrophage infiltration after ICH. Upon sorting of the infiltrating inflammatory cells into macrophages, microglia, and "other" cells ( Figure S3 ), IL23p19 mRNA was found to be expressed dominantly in the macrophages, with little expression in microglia and other cells ( Figure 4I ). Additionally, IL-23p19 mRNA expression in perihematoma tissues was markedly decreased in the CLP mice compared with the vehicle-treated groups ( Figure S2C ). These data indicate that infiltrating macrophages were the major source of IL-23p19 in the mouse brain after ICH.
To verify whether Hb is essential for IL-23p19 production, we cultured BMDCs with different concentrations of Hb for 1, 3, and 6 hours. Stimulation with 5 lmol/L Hb for 3 hours led to the greatest IL-23p19 production ( Figure 4J) , and, thus, this concentration and stimulation duration were used in subsequent experiments. Next, we investigated the relationship between TLR2/TLR4 heterodimer formation and IL-23 production. Hb-mediated induction of IL-23p19 expression was lower in TLR2 À/À and TLR4 À/À BMDCs than in WT BMDCs and lower still in TLR2 À/À /TLR4 À/À BMDCs ( Figure 4K ).
Given that MyD88 and TRIF are independent adaptor proteins in the TLR signaling pathway, they also may be involved in the Hb-mediated expression of IL-23p19 in BMDCs. We found that MyD88 À/À BMDCs produced less IL23p19 than WT BMDCs ( Figure 4K ), whereas IL-23p19 production was comparable between TRIF À/À BMDCs and WT BMDCs. These results suggest that IL-23p19 expression relies on TLR2/TLR4 heterodimer formation in a MyD88-dependent manner. Figure 5D and 5E) suggests that IL-23p19 is essential for production of IL-17 after ICH.
Finally, to verify the contribution of cdT lymphocytes in ICH-induced brain injury, cdT À/À mice were used. The NDS ( Figure 5F ), BWC ( Figure 5G ), and mRNA expression of IL-1b and TNF-a ( Figure 5H ) were significantly lower in cdT À/À mice than in WT mice after ICH.
IL-17 Played a Critical Role in ICH-Induced Secondary Brain Injury
To confirm the importance of IL-17 expression in ICH-induced secondary brain injury, we detected the dynamic expression of IL-17 in the mouse brain after ICH. Significant increases in both IL-17 protein ( Figure 6A ) and mRNA ( Figure 6B ) were observed from day 4 after ICH. We next compared the severity of ICH-induced injury between IL-17 À/À mice and WT mice.
IL-17
À/À mice had significantly lower NDS ( Figure 6C ) and BWC ( Figure 6D ), and fewer apoptotic neurons were detected in IL-17 À/À mice compared with WT mice ( Figure 6E and 6F).
However, no differences in macrophage and T-lymphocyte infiltration in response to ICH were observed between IL-17 À/ À mice and WT mice ( Figure 6G ). Still, IL-1b and TNF-a mRNA expression in perihematoma tissues was significantly lower in IL-17 À/À mice than in WT mice on day 4 after ICH ( Figure 6H ). CD45 + inflammatory cells in IL-17 À/À mice also showed lower IL-1b and TNF-a mRNA expression on day 4 after ICH compared with these cells in WT mice ( Figure 6I ). Together, these findings indicate that elevated IL-17 expression aggravated secondary brain injury after ICH, and although IL-17 deficiency was not associated with decreased infiltration of inflammatory cells, increased expression of inflammatory factors including IL-1b and TNF-a may contribute to alleviation of ICH-induced injury.
SsnB Ameliorated Secondary Brain Injury After ICH by Disrupting TLR2/TLR4 Heterodimer Formation
Because our results indicate that TLR2/TLR4 heterodimer formation is essential for secondary injury following ICH, disruption of TLR2/TLR4 heterodimer formation may be a potential therapeutic strategy for ICH. We previously found that SsnB, a monomer component of Chinese traditional herbs ( Figure S5A ), can reduce lipopolysaccharide (LPS)-induced inflammatory injury, which suggested that SsnB may inhibit the TLR pathway. 26, 37 In the present study, immunoprecipitation indicated that SsnB inhibited TLR2/TLR4 heterodimer formation on cultured BMDCs ( Figure 7A ). We further examined the inhibitory activity of derivatives of SsnB ( Figure S5B ). SA3 treatment inhibited formation of TLR2/ TLR4 heterodimer, whereas SsnB exhibited the greatest potential to inhibit TLR2/TLR4 heterodimer formation (Figure 7A) . Furthermore, TLR2/TLR4 heterodimer formation was inhibited by SsnB in a dose-dependent manner ( Figure 7B) , with a high dose (50 lmol/L) of SsnB completely abolished Hb-induced TLR2/TLR4 heterodimer formation ( Figure 7B ). Based on the involvement of TLR2/TLR4 heterodimer in Hb-mediated expression of IL-23p19, we detected IL-23p19 in SsnB-treated BMDCs and observed a reduction in IL-23p19 expression ( Figure 7C ). NF-jB activity assays were performed to test the ability of SsnB to inhibit the inflammatory reaction. Before the test, HEK-293 cells were transfected with TLR2, TLR4, and MyD88 containing pcDNA3.1. SsnB significantly inhibited NF-jB activity in HEK-293 cells transfected with both TLR2 and TLR4, but the activity remained unchanged in HEK-293 cells expressing only TLR2 or TLR4 ( Figure 7D ). These results indicate that SsnB inhibited NF-jB activity by interrupting TLR2/TLR4 heterodimer formation. Furthermore, compared with that in control MyD88-expressing HEK-293 cells, NF-jB activity was significantly reduced in MyD88 nonexpressing HEK-293 cells ( Figure 7E ). This finding confirmed that MyD88 was essential for TLR2/TLR4 heterodimer formation, and the inhibitory effect of SsnB may be related to MyD88. Our previous research demonstrated that mutation of residue Arg196 of MyD88 can interrupt TLR2/TLR4 dimerization, 22 which together with our present findings suggests that residue Arg196 on MyD88 may be the active site of SsnB. In support of this notion, a mutation assay showed that NF-jB activity was significantly inhibited when SsnB was added to HEK-293 cells expressing normal MyD88, while the NF-jB activity was both significantly inhibited in cells expressing mutant MyD88 and showed no significant difference with the absence or presence of SsnB ( Figure 7E ).
To further investigate whether SsnB treatment benefits ICH model mice, we first examined the ability of SsnB to cross the BBB. Indeed, SsnB was detected in the brains of ICH mice by LC-MS ( Figure S6) . Then, the effect of SsnB on ICH-induced injury in mice was evaluated. SsnB (5 mg/kg) was injected intravenously into mice 2 hours after ICH and then once daily for the next 3 days. Compared with the vehicle treatment, SsnB treatment led to a decreased NDS ( Figure 7F ), BWC ( Figure 7G ), and expression of proinflammatory factors including IL-23p19, IL-17 ( Figure 7H ), IL-1b, and TNF-a ( Figure 7I ). In addition, SsnB had no effect on the rectal temperature and peripheral white cell counts before and after ICH (Table S3) , which suggests that SsnB treatment did not increase the risk of secondary infection. Together, our data indicate that SsnB significantly inhibited TLR2/TLR4 heterodimer formation and ameliorated secondary brain injury after ICH. 
Discussion
The peripheral inflammatory cells responsible for neuroinflammation play important roles in the secondary brain injury that occurs after ICH, but the precise roles and mechanisms remain to be elucidated. The results of the present study revealed that infiltrating macrophages and cdT cells could worsen the secondary injury after ICH. We found that: (1) Hb from the hematoma could activate infiltrating macrophages to secrete IL-23 by inducing formation of TLR2/TLR4 heterodimer; (2) IL-23 derived from activated macrophages could drive IL-17 production by cdT cells and further increase neuroinflammation and secondary injury after ICH; and (3) SsnB could ameliorate secondary brain injury of ICH by disrupting TLR2/TLR4 heterodimer formation. Together, these findings reveal the mechanisms of neuroinflammation in ICHinduced secondary brain injury and provide new insight for the development of a novel targeted ICH therapy. Our previous research revealed that during the hyperacute phase (<6 hours) of ICH, Hb from the hematoma can induce TLR2/TLR4 heterodimer formation on microglia. In the present study, we also found that only Hb from the hematoma could induce heterodimer formation on BMDCs, whereas other components including hemin, bilirubin, Fe 2+ , and Fe 3+ have little effect on formation of the heterodimer. Furthermore, the TLR2/TLR4 heterodimer could only be detected on macrophages that had infiltrated the central nervous system, but not on the peripheral macrophages in the spleen. These results suggest that formation of the heterodimer may be closely related to the CNS microenvironment. Finally, compared with those of WT BM-transplanted TLR2 À/À /TLR4 À/À mice, the NDS, BWC, and percentage of apoptotic neurons were all significantly decreased in TLR2
À/À /TLR4 À/À BM-transplanted WT mice. Thus, the heterodimer on peripheral inflammatory cells plays a more important role than the heterodimer on the resident microglia. In conclusion, Hb from the hematoma could induce activation of both microglia and macrophages by inducing TLR2/TLR4 heterodimer formation, but the infiltrating macrophages may be more important in ICH-induced inflammatory injury. Accordingly, another study also indicated that macrophages have higher phagocytic and inflammatory potential than the microglia at the onset of neuroinflammation. 38 Peroxiredoxin originating from degenerating neurons was shown to induce macrophage release of IL-23 through TLR2 and TLR4 signaling, which is an initiator of postischemic inflammation in the brain. 21 Administration of SsnB 2 hours after ICH dramatically reduced neuroinflammation corresponding to the secondary injury. Because microglia are activated within minutes after ICH, 42, 43 inhibition of TLR2/TLR4 heterodimer formation on microglia seems difficult. Macrophages instead accumulate and become activated during the first 24 hours after ICH, which offers a prolonged therapeutic window. We propose that the clinical benefit of SsnB administrated 2 hours after ICH may be due to inhibition of heterodimer formation on macrophages. Furthermore, we demonstrated that SsnB can penetrate the BBB, which is important for inhibition of neuroinflammation in ICH. Nonetheless, inflammation is generally considered a "double-edged sword," because the use of anti-inflammatory drugs may increase the risk of secondary infection. Our findings that SsnB had no effect on rectal temperature and peripheral white cell counts before and after ICH suggest that SsnB did not increase the chance of secondary infection after ICH in our model. Therefore, SsnB warrants further testing as a potentially safe and efficient agent in ICH therapy.
Conclusions
The present study showed that Hb from the hematoma formed upon ICH induced the formation of TLR2/TLR4 heterodimer to activate IL-23 secretion by infiltrating macrophages. This macrophage-derived IL-23 induced cdT cell production of IL-17, which exacerbated the secondary brain injury after ICH in mice by amplifying the secretion of proinflammatory factors (Figure 8 ). Finally, SsnB may be able to ameliorate secondary brain injury in ICH by disrupting the formation of TLR2/TLR4 heterodimer. 
